NCT06213311
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
B Cell Lymphoma
Explore clinical trials studying B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
41 public trials
14 recruiting studies
B Cell Lymphoma trial results
NCT07048353
- Conditions
- B Cell Lymphoma, CD30+ Peripheral T-cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Tongji Hospital Affiliated to Tongji Medical College of HUST Wuhan, Hubei, China
NCT06742996
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- Ucsf Fresno Fresno, California, United States
- Kaiser Permanente Southern California Irvine, California, United States
NCT06131801
- Conditions
- ALL, AML, Acute Lymphocytic Leukemia, +50 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Texas Children's Hospital Houston, Texas, United States
NCT07584889
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B Cell Lymphoma, +16 more
- Locations
-
- Shenzhen University General Hospital Shenzhen, Other (Non U.s.), China
NCT07093073
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Tongji Hospital of Tongji University Shanghai, China
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
NCT07270835
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT06485076
- Conditions
- Aggressive Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT06976437
- Conditions
- B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China